VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, January 5, 2026
Stock Comparison
Legrand S.A. vs Novo Nordisk A/S
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Legrand S.A.
LR · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Novo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisComparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 68 / 100 for Legrand S.A.).
- Segment focus: Legrand S.A. has 2 segments (80% in Building electrical & digital infrastructure (non-datacenter)); Novo Nordisk A/S has 3 segments (71.1% in Diabetes care).
- Moat breadth: Legrand S.A. has 4 moat types across 3 domains; Novo Nordisk A/S has 5 across 3.
Primary market context
Legrand S.A.
Building electrical & digital infrastructure (non-datacenter)
Low-voltage electrical and digital building infrastructure (wiring devices, energy distribution, cable management, building controls)
Global (strong Europe & North America footprint)
Professional installers/electricians, electrical wholesalers, OEM/contractors; end-users in residential & commercial buildings
Manufacturer + brand owner; channel-driven distribution
80%
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
Side-by-side metrics
Moat coverage
Shared moat types
Legrand S.A. strengths
Novo Nordisk A/S strengths
Segment mix
Legrand S.A. segments
Full profile >Building electrical & digital infrastructure (non-datacenter)
Oligopoly
Datacenter infrastructure
Oligopoly
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.